Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 11627
  • 11628
  • 11629
  • …
  • ›
  • »

2024-11-04

IN BRIEF: Tissue Regenix contacts firms as it considers possible sale

2024-11-04

Affimed files for $20M mixed securities shelf

2024-11-04

Clean Power Hydrogen signs license agreement with Hidrigin for electrolyser manufacturing in Ireland

2024-11-04

Flora Growth Inks Medical Marijuana Supply Agreement With Curaleaf

2024-11-04

OUTFRONT Media Announces New Date and Time For 2024 Third Quarter Results

2024-11-04

Groupe Berkem Launches RECELLCL′IN®, Its New Active Ingredient Dedicated to the Cosmetic Market

2024-11-04

Elior: Outstanding Shares and Voting Rights – Monthly Statement

2024-11-04

Ikonisys to Start Collaboration with SYNLAB Italy to Introduce Ikoniscope in Pathology Laboratories

2024-11-04

Exclusive Networks – Third Quarter 2024 Financial Update

2024-11-04

EQS-Adhoc: infas Holding Aktiengesellschaft: Further examination of the ongoing public takeover offer by the Federal Cartel Office

2024-11-04

PHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.

2024-11-04

Vicat Q3 2024 Sales

  • «
  • ‹
  • …
  • 11627
  • 11628
  • 11629
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 08/Apr/2026 14:29:32
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies